Barclays’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-198
| Closed | -$1.54K | – | 5519 |
|
|
2025
Q3 | $1.54K | Sell |
198
-193
| -49% | -$1.45K | ﹤0.01% | 5161 |
|
|
2025
Q2 | $2.89K | Sell |
391
-4,478
| -92% | -$39.3K | ﹤0.01% | 5012 |
|
|
2025
Q1 | $41.9K | Sell |
4,869
-2,439
| -33% | -$37.6K | ﹤0.01% | 4665 |
|
|
2024
Q4 | $261K | Sell |
7,308
-12,473
| -63% | -$645K | ﹤0.01% | 4183 |
|
|
2024
Q3 | $935K | Buy |
19,781
+4,872
| +33% | +$215K | ﹤0.01% | 3396 |
|
|
2024
Q2 | $749K | Sell |
14,909
-1,460
| -9% | -$106K | ﹤0.01% | 2776 |
|
|
2024
Q1 | $1.83M | Buy |
16,369
+10,286
| +169% | +$1.02M | ﹤0.01% | 2642 |
|
|
2023
Q4 | $353K | Buy |
6,083
+4,717
| +345% | +$190K | ﹤0.01% | 4105 |
|
|
2023
Q3 | $43.4K | Sell |
1,366
-6,111
| -82% | -$290K | ﹤0.01% | 3930 |
|
|
2023
Q2 | $615K | Sell |
7,477
-444
| -6% | -$65K | ﹤0.01% | 2625 |
|
|
2023
Q1 | $814K | Sell |
7,921
-1,363
| -15% | -$191K | ﹤0.01% | 2895 |
|
|
2022
Q4 | $1.36M | Buy |
9,284
+3,855
| +71% | +$652K | ﹤0.01% | 2556 |
|
|
2022
Q3 | $918K | Buy |
5,429
+4,066
| +298% | +$661K | ﹤0.01% | 2308 |
|
|
2022
Q2 | $157K | Sell |
1,363
-300
| -18% | -$28.2K | ﹤0.01% | 3562 |
|
|
2022
Q1 | $166K | Sell |
1,663
-1,942
| -54% | -$227K | ﹤0.01% | 3535 |
|
|
2021
Q4 | $561K | Buy |
3,605
+2,284
| +173% | +$444K | ﹤0.01% | 3155 |
|
|
2021
Q3 | $312K | Sell |
1,321
-974
| -42% | -$285K | ﹤0.01% | 3408 |
|
|
2021
Q2 | $778K | Sell |
2,295
-2,722
| -54% | -$1.03M | ﹤0.01% | 2823 |
|
|
2021
Q1 | $2.03M | Buy |
5,017
+4,192
| +508% | +$2.03M | ﹤0.01% | 2259 |
|
|
2020
Q4 | $549K | Sell |
825
-332
| -29% | -$185K | ﹤0.01% | 3181 |
|
|
2020
Q3 | $538K | Buy |
1,157
+31
| +3% | +$15.7K | ﹤0.01% | 3182 |
|
|
2020
Q2 | $659K | Buy |
1,126
+88
| +8% | +$30.1K | ﹤0.01% | 3105 |
|
|
2020
Q1 | $151K | Sell |
1,038
-692
| -40% | -$121K | ﹤0.01% | 4502 |
|
|
2019
Q4 | $248K | Buy |
1,730
+561
| +48% | +$41K | ﹤0.01% | 4869 |
|
|
2019
Q3 | $46K | Buy |
1,169
+37
| +3% | +$2.69K | ﹤0.01% | 5947 |
|
|
2019
Q2 | $115K | Buy |
1,132
+590
| +109% | +$69.5K | ﹤0.01% | 5582 |
|
|
2019
Q1 | $71K | Buy |
542
+365
| +206% | +$45.9K | ﹤0.01% | 5631 |
|
|
2018
Q4 | $18K | Sell |
177
-190
| -52% | -$30.1K | ﹤0.01% | 5956 |
|
|
2018
Q3 | $92K | Buy |
367
+262
| +250% | +$87.8K | ﹤0.01% | 5622 |
|
|
2018
Q2 | $46K | Sell |
105
-65
| -38% | -$28.5K | ﹤0.01% | 5689 |
|
|
2018
Q1 | $68K | Buy |
170
+138
| +431% | +$54.5K | ﹤0.01% | 5655 |
|
|
2017
Q4 | $13K | Sell |
32
-120
| -79% | -$52.3K | ﹤0.01% | 6448 |
|
|
2017
Q3 | $66K | Buy |
+152
| New | +$59.9K | ﹤0.01% | 5192 |
|
Other funds holding MRSN
NI
BCLSI
RSCM
AV
AAA
